Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: TRK-b agonists for BDNF knockouts

Posted by linkadge on September 15, 2014, at 20:03:59

In reply to Re: TRK-b agonists for BDNF knockouts, posted by linkadge on September 15, 2014, at 19:57:40

BDFN is an interesting target. Enhancement of BDNF signalling interacts with P11 to enhance the surface expression of 5-ht1b receptors. It also can increase reward sensitivity via enhancing dopamine d3 expression. I think there is interaction too with gsk3. I think gsk3 inhibitors can enhance BDNF. I remember reading that ketamine's enhancement of BDNF was abolished if the effect of gsk3 was abolished.

I just have a surface knowledge though.

Linkadge


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


[1071189]

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:linkadge thread:1071129
URL: http://www.dr-bob.org/babble/20140914/msgs/1071189.html